Foundation Medicine, Karyopharm Therapeutics Partnering on Endometrial Cancer CDx
The test would help identify patients who have advanced or recurrent TP53 wild-type endometrial cancer and could benefit from the experimental drug Xpovio.
European Team Publishes Molecular Endometrial Cancer Test; Startup Sola Dx Plans Fall Launch
Called WID-qEC, the test uses quantitative PCR methylation profiling to diagnose endometrial cancer in women presenting with symptoms.
Akoya Biosciences, Acrivon Therapeutics Partner to Develop CDx
The companies will codevelop, validate, and commercialize a companion diagnostic for Acrivon's targeted DNA damage response inhibitor therapy, ACR-368.
Gynecological Cancer Regulatory, Expression Features Found Using Single-Cell Profiling
Researchers explored gene expression, transcription factor, and other regulatory relationships with single-cell data on more than 170,000 ovarian or endometrial tumor cells.
NCI researchers performed a multi-platform study to elucidate the factors that can contribute to a patient's better-than-expected response to a drug.